Dynamic Advisor Solutions’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.94M Buy
12,243
+489
+4% +$66.1K 0.05% 344
2026
Q1
$1.5M Buy
11,754
+161
+1% +$20.1K 0.05% 375
2025
Q4
$1.41M Sell
11,593
-145
-1% -$16.6K 0.05% 379
2025
Q3
$1.18M Sell
11,738
-332
-3% -$29.9K 0.03% 429
2025
Q2
$1M Buy
12,070
+1,895
+19% +$151K 0.03% 458
2025
Q1
$825K Buy
+10,175
New +$909K 0.03% 466
2024
Q4
Sell
-15,276
Closed -$1.51M 932
2024
Q3
$1.51M Buy
15,276
+209
+1% +$20.5K 0.05% 356
2024
Q2
$1.4M Sell
15,067
-224
-1% -$20.1K 0.04% 369
2024
Q1
$1.45M Sell
15,291
-1,930
-11% -$179K 0.05% 360
2023
Q4
$1.54M Sell
17,221
-601
-3% -$44.6K 0.06% 325
2023
Q3
$1.3M Sell
17,822
-658
-4% -$52.6K 0.06% 298
2023
Q2
$1.54M Buy
18,480
+132
+0.7% +$11K 0.08% 259
2023
Q1
$1.4M Buy
18,348
+4,949
+37% +$411K 0.08% 260
2022
Q4
$1.11M Buy
13,399
+300
+2% +$24.3K 0.08% 265
2022
Q3
$1.04M Sell
13,099
-106
-0.8% -$8.94K 0.08% 242
2022
Q2
$981K Sell
13,205
-28,271
-68% -$2.12M 0.08% 249
2022
Q1
$3.73M Buy
41,476
+37,857
+1,046% +$3.5M 0.26% 92
2021
Q4
$405K Buy
+3,619
New +$436K 0.03% 488
2021
Q1
Sell
-5,152
Closed -$725K 782
2020
Q4
$725K Sell
5,152
-213
-4% -$27.3K 0.07% 293
2020
Q3
$598K Sell
5,365
-7
-0.1% -$785 0.07% 278
2020
Q2
$601K Buy
5,372
+985
+22% +$97K 0.08% 250
2020
Q1
$340K Hold
4,387
0.06% 313
2019
Q4
$417K Sell
4,387
-375
-8% -$32.4K 0.06% 342
2019
Q3
$363K Sell
4,762
-164
-3% -$13.6K 0.06% 333
2019
Q2
$432K Buy
4,926
+697
+16% +$59.5K 0.07% 289
2019
Q1
$383K Sell
4,229
-62
-1% -$5.27K 0.07% 262
2018
Q4
$353K Buy
4,291
+330
+8% +$26.6K 0.08% 254
2018
Q3
$380K Buy
3,961
+30
+0.8% +$2.91K 0.08% 256
2018
Q2
$374K Sell
3,931
-200
-5% -$18.4K 0.08% 262
2018
Q1
$362K Buy
4,131
+277
+7% +$25.3K 0.09% 230
2017
Q4
$327K Buy
3,854
+100
+3% +$8.38K 0.11% 190
2017
Q3
$325K Buy
3,754
+290
+8% +$23.2K 0.13% 173
2017
Q2
$267K Hold
3,464
0.1% 185
2017
Q1
$240K Sell
3,464
-135
-4% -$9.07K 0.09% 188
2016
Q4
$213K Sell
3,599
-330
-8% -$20.4K 0.08% 201
2016
Q3
$260K Buy
3,929
+115
+3% +$7.11K 0.1% 205
2016
Q2
$206K Buy
+3,814
New +$209K 0.08% 198
2016
Q1
Sell
-3,832
Closed -$269K 215
2015
Q4
$269K Sell
3,832
-20
-0.5% -$1.36K 0.11% 186
2015
Q3
$240K Buy
3,852
+75
+2% +$5.91K 0.12% 156
2015
Q2
$318K Buy
3,777
+15
+0.4% +$1.17K 0.19% 119
2015
Q1
$283K Buy
3,762
+243
+7% +$17K 0.14% 154
2014
Q4
$219K Buy
+3,519
New +$201K 0.12% 172

Other funds holding XBI

Dynamic Advisor Solutions's XBI Position: Q2 2026 in Review

Dynamic Advisor Solutions increased its State Street SPDR S&P Biotech ETF (XBI) stake by 4.2% in Q2 2026, buying an estimated $66.1K and bringing the position to 12,243 shares worth $1.94M. The position accounts for 0.05% of the portfolio, ranked #344.

Dynamic Advisor Solutions first reported a position in XBI in Q4 2014 and has held it in 42 quarters since. The position peaked at $3.73M in Q1 2022. 131 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

  • Dynamic Advisor Solutions held 12,243 shares of State Street SPDR S&P Biotech ETF worth $1.94M as of Q2 2026.
  • Dynamic Advisor Solutions bought 489 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $66.1K.
  • State Street SPDR S&P Biotech ETF made up 0.05% of Dynamic Advisor Solutions's portfolio in Q2 2026, its #344 holding.
  • Dynamic Advisor Solutions first reported a position in State Street SPDR S&P Biotech ETF in Q4 2014 and has held it in 42 quarters since.
  • Dynamic Advisor Solutions's State Street SPDR S&P Biotech ETF position peaked at $3.73M in Q1 2022.
  • 131 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Dynamic Advisor Solutions's 13F filing for Q2 2026, filed 7 Jul 2026.